BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
BIOXYTRAN, INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026
- Market cap
- $2.56M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0430 (−65.75%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $2.56M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$3.49M
- EPS, diluted
- -$0.04
- Book value per share
- -$0.04
- Diluted shares
- 114M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$3.69M
Net income
-$3.49M
EPS, diluted
-$0.04
Reported periodTrailing twelve months